维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Lurkin"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Spectrum of KIT/ PDGFRA/BRAF mutations and l?hosphatidylinositol-3-Kinase pathway geue alterations in gastrointestinal stromal tumors (GIST) 显示文摘	Daniels M Lurkin I Pauli R	2011	Cancer Lett2011，312，：	1
2	The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate显示文摘	Van-Rhi jn BW Lurkin 1 Radvanyi F	2001	Cancer Res2001，61，4：	1
3	FGFR3, HRAS,KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy 显示文摘	Kompier LC Lurkin I van der Aa MN	2010	PLoS One2010，5，11：	1
4	Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing显示文摘	Ducimetière F Lurkin A Ranchère-Vince D	2011	PLo S One2011，6，20：	1
5	A prospective epidemiological study of new incident GISTSs during two consecutive years in rhone alpes region:incidence and molecular distribution of GISTs in a European region显示文摘	Cassier PA Ducimetiere F Lurkin A	2010	Br J Cancer2010，103，：	1
6	The fibroblast growth factor receptor 3 (FGFR3)mutation is a strong indicator of superficial bladder cancer with lowrecurrence rate显示文摘	Van Rhijn BW Lurkin I Radvanyi F	2001	Cancer Res2001，61，：	1
7	Sarcomas and malignant phyllodes tumours of the breast-a retrospective study 显示文摘	Confavreux C Lurkin A Mitton N	2006	Eur J Cancer2006，42，16：	1
8	FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy显示文摘	Kompier LC Lurkin I van der Aa MN	2010	PIoS One2010，5，11：	1
9	A prospective epidemiologieal study of new incident GISTs during two consecutive years in Rhone Alpes region: incidence and molecular distribution of GIST in a European region 显示文摘	Cassier PA Ducimetiere F Lurkin A	2010	Br J Cancer2010，103，：	1
10	The fibroblast growth factor receptor 3(FGFR3)mutation is a strong indicator of superficial bladder cancer with low recurrence rate显示文摘	van Rhijn BW Lurkin I Radvanyi F	2001	Cancer Res2001，61，4：	1
11	Sarcomas and malignantphyllodes tumors of the breast-a retrospective study显示文摘	Confavreux C Lurkin A Mitton N		0，，16：	1
12	Combinedmicrosatellite and FGFR3mutation analysis enables ahighly sensitive detection of urothelial cell carcinoma in voided urine显示文摘	van Rhijn BW Lurkin I Chopin DK etal	2003	Clin Cancer Res2003，9，1：	1
13	A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine显示文摘	van Oers JM Lurkin I van Exsel A J	2005	Clin Cancer Res2005，11，21：	1
14	Sarcomas and malignant phyllodes tumours of the breast--a retrospective study显示文摘	Confavreux C Lurkin A Mitton N	2006	Eur J Cancer2006，42，16：	1
15	A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine显示文摘	VAN OERS J M LURKIN I VAN EXSEL A J	2005	Clin Cancer Res2005，11，21：	1
16	Sarcomas and malignant phyllodes tumours of the breast--a retrospective study 显示文摘	Confavreux C Lurkin A Mitton N	2006	Eur J Cancer2006，42，16：	1
17	Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing显示文摘	Ducimetiere F Lurkin A Ranchere-Vince D		0，，：	1
18	Sarcomas and malignant phyllodes tumours of the breast-A retrospective study显示文摘	Confavreux C Lurkin A Mitton N	2006	Eur J Cancer2006，42，16：	1
19	FGFR3, HRas, KRas, NRas and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy 显示文摘	Kompier L C Lurkin I van der Aa M N	2010	PLoS One2010，5，13：	1
20	Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detectionof urothelial cell carcinoma in voided urine显示文摘	van Rhijn B W Lurkin I Chopin D K	2003	Clin Cancer Res2003，9，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示